Darwin Global Management, Ltd.

Darwin Global Management, Ltd. reported 5 holdings worth US$3.99B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Darwin Global Management, Ltd. reported 5 holdings worth US$3.99B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Genmab A/S and Belite Bio, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
5
Value as reported
US$3.99B

The filing in full

CompanySharesValue as reported% of portfolio
Revolution Medicines, Inc.10.6MUS$2.18B54.7%
Genmab A/S17.9MUS$639M16.0%
Belite Bio, Inc.3.1MUS$526M13.2%
Abivax SA4.02MUS$398M10.0%
Roivant Sciences Ltd.6.75MUS$247M6.2%
Insmed Incorporated0US$00.00%

Source

Download original · View original at SEC

Related